BALAXI PHARMA | O P CHAINS | BALAXI PHARMA/ O P CHAINS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -123.7 | -183.6 | - | View Chart |
P/BV | x | 3.7 | 0.7 | 571.5% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BALAXI PHARMA O P CHAINS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BALAXI PHARMA Mar-23 |
O P CHAINS Mar-23 |
BALAXI PHARMA/ O P CHAINS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 706 | 22 | 3,261.0% | |
Low | Rs | 304 | 11 | 2,698.2% | |
Sales per share (Unadj.) | Rs | 330.5 | 2.2 | 15,224.1% | |
Earnings per share (Unadj.) | Rs | 45.2 | 3.4 | 1,339.5% | |
Cash flow per share (Unadj.) | Rs | 46.9 | 3.4 | 1,390.5% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 169.5 | 47.5 | 357.1% | |
Shares outstanding (eoy) | m | 10.18 | 6.85 | 148.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.5 | 7.6 | 20.2% | |
Avg P/E ratio | x | 11.2 | 4.9 | 229.1% | |
P/CF ratio (eoy) | x | 10.8 | 4.9 | 220.7% | |
Price / Book Value ratio | x | 3.0 | 0.3 | 859.3% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 5,139 | 113 | 4,560.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 290 | 1 | 53,618.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,364 | 15 | 22,624.9% | |
Other income | Rs m | 26 | 24 | 110.0% | |
Total revenues | Rs m | 3,391 | 39 | 8,727.7% | |
Gross profit | Rs m | 574 | -1 | -78,650.7% | |
Depreciation | Rs m | 18 | 0 | - | |
Interest | Rs m | 14 | 0 | - | |
Profit before tax | Rs m | 569 | 23 | 2,448.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 110 | 0 | 64,470.6% | |
Profit after tax | Rs m | 460 | 23 | 1,990.6% | |
Gross profit margin | % | 17.1 | -4.9 | -348.6% | |
Effective tax rate | % | 19.3 | 0.7 | 2,656.7% | |
Net profit margin | % | 13.7 | 155.3 | 8.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,935 | 137 | 1,410.8% | |
Current liabilities | Rs m | 531 | 0 | 241,513.6% | |
Net working cap to sales | % | 41.7 | 920.9 | 4.5% | |
Current ratio | x | 3.6 | 623.5 | 0.6% | |
Inventory Days | Days | 2 | 4,618 | 0.0% | |
Debtors Days | Days | 567 | 0 | - | |
Net fixed assets | Rs m | 462 | 188 | 245.2% | |
Share capital | Rs m | 102 | 69 | 148.6% | |
"Free" reserves | Rs m | 1,624 | 257 | 632.7% | |
Net worth | Rs m | 1,726 | 325 | 530.7% | |
Long term debt | Rs m | 9 | 0 | - | |
Total assets | Rs m | 2,397 | 325 | 736.5% | |
Interest coverage | x | 42.3 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.4 | 0 | 3,071.9% | |
Return on assets | % | 19.8 | 7.1 | 278.4% | |
Return on equity | % | 26.6 | 7.1 | 375.1% | |
Return on capital | % | 33.6 | 7.2 | 470.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 802 | 0 | - | |
Fx outflow | Rs m | 40 | 0 | - | |
Net fx | Rs m | 763 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 61 | -82 | -74.1% | |
From Investments | Rs m | -106 | 82 | -129.3% | |
From Financial Activity | Rs m | 255 | NA | - | |
Net Cashflow | Rs m | 210 | 0 | -95,554.5% |
Indian Promoters | % | 66.9 | 74.5 | 89.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 17.2 | 0.0 | - | |
FIIs | % | 17.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 33.1 | 25.5 | 130.1% | |
Shareholders | 5,206 | 46 | 11,317.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BALAXI PHARMA With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BALAXI PHARMA | O P CHAINS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.68% | 0.00% | 0.45% |
1-Month | 18.41% | 0.00% | 2.55% |
1-Year | 9.82% | 139.15% | 56.14% |
3-Year CAGR | -0.13% | 41.39% | 15.22% |
5-Year CAGR | 45.18% | 23.10% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the BALAXI PHARMA share price and the O P CHAINS share price.
Moving on to shareholding structures...
The promoters of BALAXI PHARMA hold a 66.9% stake in the company. In case of O P CHAINS the stake stands at 74.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BALAXI PHARMA and the shareholding pattern of O P CHAINS.
Finally, a word on dividends...
In the most recent financial year, BALAXI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
O P CHAINS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of BALAXI PHARMA, and the dividend history of O P CHAINS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.